<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01232985</url>
  </required_header>
  <id_info>
    <org_study_id>MIC-AD-001</org_study_id>
    <nct_id>NCT01232985</nct_id>
  </id_info>
  <brief_title>Efficacy and Tolerability Study of Device, RD047-26 for the Treatment of Mild to Moderate Atopic Dermatitis in Adults</brief_title>
  <official_title>An Open-Label Pilot Study to Determine the Efficacy and Tolerability of a Device, RD047-26 for the Treatment of Mild to Moderate Atopic Dermatitis With Associated Pruritus in Adults</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Oculus Innovative Sciences, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Oculus Innovative Sciences, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to find out if investigational device, RD047-26, is safe and
      useful for the treatment of mild to moderate atopic dermatitis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      RD047-26, a device, may be tolerable and effective for the treatment of mild to moderate
      atopic dermatitis with associated pruritus in adults. The treatment effect will be evaluated
      by the subject and investigator.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2010</start_date>
  <completion_date type="Actual">December 2010</completion_date>
  <primary_completion_date type="Actual">December 2010</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Investigator Global Assessment</measure>
    <time_frame>2 weeks</time_frame>
    <description>Investigator Global Assessment of Atopic Dermatitis Severity</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Investigator Pruritus Assessment</measure>
    <time_frame>2 weeks</time_frame>
    <description>Investigator Pruritus Severity Assessment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subject Itch Assessment</measure>
    <time_frame>2 weeks</time_frame>
    <description>Subject assessment of itch severity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse Events</measure>
    <time_frame>2 weeks</time_frame>
    <description>Number of subjects with related adverse events</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">17</enrollment>
  <condition>Atopic Dermatitis</condition>
  <condition>Pruritus</condition>
  <arm_group>
    <arm_group_label>RD047-26</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Study Device</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>RD047-26</intervention_name>
    <description>RD047-26 emollient gel</description>
    <arm_group_label>RD047-26</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Written informed consent

          -  Female or male, 18 to 65 years of age and in good general health

          -  Clinical diagnosis of stable mild to moderate atopic dermatitis

          -  Willing and able to follow study instructions and likely to complete all study
             requirements

        Exclusion Criteria:

          -  Severe or uncontrolled asthma

          -  Pregnant, nursing, or planning a pregnancy during the study; or is a WOCBP but is not
             willing to use an effective method of birth control

          -  Current enrollment in an investigational drug or device study or participation in such
             a study within the last 30 days prior to Baseline (Day 0)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Zoe Draelos, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dermatology Consulting Services, High Point NC</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Dermatology Consulting Services</name>
      <address>
        <city>High Point</city>
        <state>North Carolina</state>
        <zip>27262</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 26, 2010</study_first_submitted>
  <study_first_submitted_qc>November 1, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 2, 2010</study_first_posted>
  <last_update_submitted>May 29, 2012</last_update_submitted>
  <last_update_submitted_qc>May 29, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 30, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Atopic Dermatitis</keyword>
  <keyword>Pruritus</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dermatitis</mesh_term>
    <mesh_term>Dermatitis, Atopic</mesh_term>
    <mesh_term>Eczema</mesh_term>
    <mesh_term>Pruritus</mesh_term>
  </condition_browse>
  <pending_results>
    <submitted>April 10, 2018</submitted>
    <returned>May 11, 2018</returned>
    <submitted>May 14, 2018</submitted>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

